News
A new study published in the Journal of Cosmetic Dermatology revealed that dermatologic benefits of topical omega-3 ...
From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction.
Roflumilast 0.3% cream (Zoryve), a phosphodiesterase-4 inhibitor, was approved in July 2022 for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and ...
14d
Everyday Health on MSNHow to Spot and Treat Inverse Psoriasis
Inverse psoriasis, which causes painful lesions on sensitive skin folds, can be hard to treat. Find out more about this type of psoriasis.
24d
Health on MSNWhat Is the Difference Between Psoriasis and Ringworm?
Medically reviewed by Casey Gallagher, MD Psoriasis and ringworm (tinea corporis) cause scaly rashes but have different causes and treatments. Psoriasis is an autoimmune condition, while ringworm is a ...
Researchers develop nanofiber patch for treatment of psoriasis Date: November 12, 2024 Source: University of Copenhagen - The Faculty of Health and Medical Sciences Summary: Researchers have ...
In this video, Ahmad Shatil Amin, MD, medical practice director at the Northwestern Medicine Dermatology, discusses the latest treatment options for psoriasis.
Other formulations of Zoryve include roflumilast cream 0.3% for the topical treatment of plaque psoriasis, including intertriginous areas; and roflumilast cream 0.15% for the topical treatment of ...
If you’re one of the 7.5 million people in the U.S. with psoriasis, 1 you know how important it is to find the best treatment for you. And you’re probably well aware that the road to psoriasis ...
Session ID: 2025-07-04:9426c64654ca7cd4f0d9745f Player Element ID: Va0cc0e01_e574_44c4_9c37_dba120bd3b5e_6347850733112 ...
8. Ask your doctor about medications There are topical creams or ointments, oral medications, and injections that can be used to manage psoriasis pain, Dr. Rodney says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results